An observational study in Fibrillation, Atrial and To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation Procedure, sponsored by Hospital St. Joseph, Marseille, France. Withdrawn at 3 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-28.
Sponsored by Hospital St. Joseph, Marseille, France · Observational
pilot clinical study, multicenter, prospective, open, nonrandomized
The hypothesis is that ablation targeting PVI alone for the treatment of persistent AF is less efficient that ablation targeting electrophysiologic areas with spatio-temporal-dispersion with or without PVI
major patient with an indication of AF or AT ablation
Inclusion Criteria: major patient with an indication of AF or AT ablation -
Exclusion Criteria:
-
AF termination
conversion to sinus rhythm or stable atrial tachycardia
Time frame: during the ablation procedure
AT termination
conversion to sinus rhythm
Time frame: during the ablation procedure
This study is withdrawn, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital St. Joseph, Marseille, France